Autem Therapeutics

Biotechnology Research • Hanover, New Hampshire, United States • 11-20 Employees

Company overview

Headquarters	35 S Main St, Hanover, New Hampshire 03755, US
Website	autemtherapeutics.com
NAICS	541714
SIC	873
Keywords	Medical Device, Survival, Quality Of Life, HCC, Bioelectric, Electromagnetic Frequencies (Em), Solid Tumours
Founded	2017
Employees	11-20
Socials

Key Contacts at Autem Therapeutics

Michael Choukas

Co-Founder And Chief Executive Officer

Frederico Perego Costa

Founder & Chief Scientific Officer

Autem Therapeutics Email Formats

Autem Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@autemtherapeutics.com), used 58.3% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@autemtherapeutics.com	58.3%
{first name}.{last name}	john.doe@autemtherapeutics.com	41.7%

About Autem Therapeutics

Autem Therapeutics is a privately held oncology therapeutic and bioelectric med-tech company headquartered in Hanover NH, USA that is developing a novel, non-invasive, and non-toxic pan-cancer treatment platform targeting hepatocellular carcinoma (HCC), glioblastoma (GBM) and other solid tumors. The company has received FDA breakthrough designation for its device for the treatment of advanced HCC patients. The AutEMsys device delivers personalized, amplitude-modulated electromagnetic frequencies (AM-EMF) and based on early clinical feasibility studies shows promise in shrinking cancerous tumors, enhancing quality of life, and extending survival in early and advanced stage cancer patient populations. Autem Therapeutics anticipates approval of FDA Investigational Device Exemptions (IDE) to initiate clinical trials in HCC and GBM in the second half of 2025.

Autem Therapeutics revenue & valuation

Annual revenue	$1,283,325
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,200,000
Total funding	$10,000,000

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Vice President

Entry

Founder/Owner

Employees by Department

Autem Therapeutics has 7 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Autem Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-07-06	4	$10,000,000

Funding Insights

$10,000,000

Total funding amount

$10,000,000

Most recent funding amount

Number of funding rounds

Autem Therapeutics Tech Stack

Discover the technologies and tools that power Autem Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Swiper

JavaScript libraries

jQuery UI

JavaScript libraries

Hello Elementor

WordPress themes

Elementor

Page builders

Microsoft 365

Redis

Databases

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Frequently asked questions

Autem Therapeutics is located in Hanover, New Hampshire, US.

Autem Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Autem Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Autem Therapeutics has raised a total of $10,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Autem Therapeutics

Michael Choukas

Co-Founder And Chief Executive Officer

Frederico Perego Costa

Founder & Chief Scientific Officer

4.8

40,000 users